FDA Releases Guidance for Industry on Abbreviated Reports and Synopses for Marketing Applications

Summary

The Food and Drug Administration (FDA) has made available a guidance document to help pharmaceutical companies submit abbreviated reports and synopses in support of marketing applications, allowing for more efficient review of clinical studies for new products and supplements to approved applications.